Stock Price
47.60
Daily Change
-0.58 -1.20%
Monthly
0.68%
Yearly
-12.18%
Q1 Forecast
46.71

Recordati reported EUR171.38M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
GlaxoSmithKline GBP 2.68B 518M Dec/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Orion EUR 110.7M 26.1M Dec/2025
Sanofi EUR 2.75B 455M Dec/2025